Nureca CEO Aryan Goyal resigns; shares to transfer to Saurabh Goyal
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.6 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mr. Aryan Goyal, Whole-time Director and CEO of Nureca Limited, has resigned effective close of business on July 1, 2026. The move follows a Family Settlement Agreement dated June 17, 2026, under which his entire shareholding is being transferred to Mr. Saurabh Goyal. He confirmed there are no other material reasons for stepping down from his executive and board roles.
Top leadership change. Shareholding shifts to Saurabh Goyal under a family settlement. Watch for new CEO appointment and any governance impact.